Home › Trial NCT04577833
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
- Trial IDNCT04577833
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorJanssen Research & Development, LLC
- Enrollment136
- Start date2020-11-13
- ConditionsProstatic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.